Dr Andrew Rut: Opportunities and challenges for drug safety in Japan

Dr Andrew Rut: Opportunities and challenges for drug safety in Japan

News
11/06/19

The Japanese pharmaceuticals market has undergone significant shakeup in recent years, now reaching new leagues as the third biggest pharmaceuticals market in the world.

In a recent article with Pharma Business International, Dr Andrew Rut, CEO and co-founder of MyMeds&Me, discusses the opportunities and challenges of drug safety in Japan in the face of market growth and regulatory change.

Read the article here


Access Free Demo

Plus get a fixed price pilot — fill in the details below:

For more information contact chris.beverley@mymedsandme.com

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates